Document:

EX-10.2

 Exhibit 10.2 

SUBSCRIPTION AGREEMENT 

This Subscription Agreement (“Agreement”), dated as of August 3, 2018, sets forth the terms and conditions upon which
Quotient Limited, a company organized under the laws of Jersey (the “Company”), will issue, and Heino von Prondzynski (the “Subscriber”) will subscribe for, an aggregate of 10,000 ordinary shares (the
“Shares”), of no par value per share, of the Company (for cash at a price of $7.54 per Share (the “Subscription Price”). This Agreement is being entered into prior to the close of trading on The Nasdaq Global Market
on the date of this Agreement and, accordingly, the Subscription Price per Share is equal to the closing bid price of the Company’s ordinary shares as reported on the Nasdaq Global Market on August 2, 2018. 

Section 1. Subscription and Issue of the Shares. The Company agrees to issue to the Subscriber, and the
Subscriber agrees to subscribe for, the Shares. As promptly as reasonably practicable, but in no event later than three business days after the execution of this Agreement, the Subscriber shall deliver the Subscription Price for the Shares to the
Company by wire transfer of immediately available funds in accordance with the Company’s written wire instructions. Subject to and upon receipt of such payment of the Subscription Price for the Shares, the Company shall deliver instructions to
the Company’s transfer agent to issue to the Subscriber certificates or other appropriate documentation for the Shares, duly executed on behalf of the Company and registered in the name of the Subscriber or his designee. 

Section 2. Representations and Warranties of the Subscriber. The Subscriber represents and warrants to the
Company, as of the date hereof and as of the closing date that: 
 (a) The execution, delivery and performance by the Subscriber of this
Agreement, and the consummation of the transactions contemplated hereby are within the legal right, power and capacity of the Subscriber, and that this Agreement constitutes a valid and binding agreement of the Subscriber, enforceable in accordance
with its terms, except (i) as limited by applicable bankruptcy, insolvency, reorganization, moratorium, and other laws of general application affecting enforcement or creditors’ rights generally or (ii) as limited by laws relating to
the availability of specific performance, injunctive relief, or other equitable remedies. 
 (b) The execution, delivery and performance by
the Subscriber of this Agreement and the consummation of the transactions contemplated hereby require no order, license, consent, authorization or approval of, or exemption by, or action by or in respect of, or notice to, or filing or registration
with, any governmental body, agency or official on the part of the Subscriber. 
 (c) The execution, delivery and performance by the
Subscriber and the Company of this Agreement, and the consummation of the transactions contemplated by this Agreement, do not and will not (i) violate any material agreement to which the Subscriber is a party or by which the Subscriber or any
of his property or assets is bound, or (ii) violate any law, rule, regulation, order, judgment or decree applicable to the Subscriber. 

(d) There is no investment banker, broker, finder or other intermediary which has been retained by, will be retained by or is authorized to
act on behalf of the Subscriber who might be entitled to any fee or commission from the Company or the Subscriber upon consummation of the transactions contemplated by this Agreement. 

 (e) (i) The Subscriber is knowledgeable, sophisticated and experienced in financial and
business matters, in making, and is qualified to make, decisions with respect to investments in securities representing an investment decision like that involved in the purchase of the Shares, including investments in securities issued by companies
similar to the Company in terms of the Company’s stage of development, and the Subscriber has undertaken an independent analysis of the merits and the risks of an investment in the Shares, based on the Subscriber’s own financial
circumstances; (ii) the Subscriber has had the opportunity to request, receive, review and consider, or has otherwise had access to, all information he deems relevant in making an informed decision to purchase the Shares and to ask questions
of, and receive answers from, the Company concerning such information; (iii) the Subscriber is acquiring the Shares for his own account and with no present intention of distributing any of such Shares or any arrangement or understanding with
any other persons regarding the distribution of such Shares; (iv) the Subscriber will not, directly or indirectly, offer, sell, pledge, transfer or otherwise dispose of (or solicit any offers to buy, purchase or otherwise acquire or take a
pledge of) any of the Shares, nor will the Subscriber engage in any short sale that results in a disposition of any of the Shares by the Subscriber, except in compliance with the Securities Act of 1933, as amended (the “Securities
Act”), and the rules and regulations thereunder, any applicable state securities laws and the applicable laws of Jersey, Channel Islands; and (v) the Subscriber is an “accredited investor” within the meaning of Rule 501(a) of
Regulation D under the Securities Act. 
 (f) The Subscriber understands that the Shares are being offered and sold to him in reliance upon
specific exemptions from the registration requirements of the Securities Act, the rules and regulations thereunder and state securities laws and the regulatory consent requirements under the applicable laws of Jersey, Channel Islands. The Subscriber
further understands that the Company is relying upon the truth and accuracy of, and the Subscriber’s compliance with, the representations, warranties, agreements, acknowledgments and understandings of the Subscriber set forth herein in order to
determine the availability of such exemptions and the eligibility of the Subscriber to acquire the Shares. 
 (g) The Subscriber
acknowledges that the Shares were not offered to the Subscriber by means of any form of general or public solicitation or general advertising, or publicly disseminated advertisements or sales literature, including (i) any advertisement,
article, notice or other communication published in any newspaper, magazine, website, or similar media, or broadcast over television or radio, or (ii) any seminar or meeting to which the Subscriber was invited by any of the foregoing means of
communications. 
 (h) The Subscriber understands that nothing in the Agreement or any other materials presented to the Subscriber in
connection with the purchase and sale of the Shares constitutes legal, tax or investment advice. The Subscriber has consulted such legal, tax and investment advisors as he, in his sole discretion, has deemed necessary or appropriate in connection
with his purchase of the Shares. 
 (i) The Subscriber understands that his investment in the Shares involves a significant degree of risk,
including a risk of total loss of the Subscriber’s investment, and the Subscriber has full cognizance of and understands all of the risks related to the Subscriber’s purchase of the Shares. 

 (j) The Subscriber understands that the Shares will be “restricted securities” as
such term is used in Rule 144 under the Securities Act and will bear a restrictive legend restricting the transfer of such Shares in connection therewith. 

Section 3. Representations and Warranties of the Company. The Company represents and warrants to the Subscriber,
as of the date hereof and as of the closing date that: 
 (a) The execution, delivery and performance by the Company of this Agreement, and
the consummation of the transactions contemplated hereby and thereby are within the powers of the Company and have been or will have been duly authorized by all necessary action on the part of the Company, and that this Agreement constitutes a valid
and binding agreement of the Company, enforceable in accordance with its terms, except (i) as limited by applicable bankruptcy, insolvency, reorganization, moratorium, and other laws of general application affecting enforcement or
creditors’ rights generally or (ii) as limited by laws relating to the availability of specific performance, injunctive relief, or other equitable remedies. 

(b) The execution, delivery and performance by the Company of this Agreement and the consummation of the transactions contemplated hereby
require no order, license, consent, authorization or approval of, or exemption by, or action by or in respect of, or notice to, or filing or registration with, any governmental body, agency or official on the part of the Company. 

(c) The execution, delivery and performance by the Subscriber and the Company of this Agreement, and the consummation of the transactions
contemplated by this Agreement, do not and will not (i) violate the certificate of incorporation (or certificate of incorporation on change of name) of the Company or the articles of association of the Company, (ii) violate any material
agreement to which the Company is a party or by which the Company or any of its property or assets is bound, or (iii) violate any law, rule, regulation, order, judgment or decree applicable to the Company. 

(d) The Shares, when issued upon payment of the Subscription Price therefor in accordance herewith, will be duly authorized and validly
issued, fully-paid and non-assessable. 
 (e) There is no investment banker, broker, finder or
other intermediary which has been retained by, will be retained by or is authorized to act on behalf of the Company who might be entitled to any fee or commission from the Company or the Subscriber upon consummation of the transactions contemplated
by this Agreement. 
 Section 4. Survival; Indemnity. The representations and warranties of the parties hereto
contained in this Agreement shall survive the consummation of the transactions contemplated hereby. The Subscriber and the Company agree to indemnify and protect the other party, his or its employees, contractors, agents and attorneys, as
applicable, and his or its successors and assigns and hold them harmless from and against any and all losses, liabilities, costs and expenses (including reasonable attorneys’ fees) incurred as a result of the breach by the Subscriber or the
Company, as applicable, of any of his or its representations, warranties or covenants contained in this Agreement. 

 Section 5. Notices. All notices, requests and other
communications to any party hereunder shall be in writing (including facsimile transmission) and shall be given, 
 if to the Subscriber to:

 Heino von Prondzynski 

[address to be inserted] 
 if to
the Company to: 
 Quotient Limited 

28 Esplanade 
 St Helier 

Jersey JE2 3QA 
 Channel Islands

 Attn: Christopher Lindop 

With a copy to: 
 Clifford
Chance US LLP 
 31 West 52nd St. 

New York, NY 10019 
 Fax: (212) 878-8375 
 Attention: Per Chilstrom 

or to such other address or telecopy number and with such other copies as such party may hereafter specify for the purpose of notice. All such notices,
requests and other communications shall be deemed received on the date of receipt by the recipient thereof if received prior to 5 p.m. in the place of receipt and such day is a business day in the place of receipt. Otherwise, any such notice,
request or communication shall be deemed not to have been received until the next succeeding business day in the place of receipt. 

Section 6. Amendments and Waivers. Any provision of this Agreement may be amended or waived if, but only if, such
amendment or waiver is in writing and is signed, in the case of an amendment, by each party to this Agreement, or in the case of a waiver, by the party against whom the waiver is to be effective. No failure or delay by any party in exercising any
right, power or privilege hereunder shall operate as a waiver thereof nor shall any single or partial exercise thereof preclude any other or further exercise thereof or the exercise of any other right, power or privilege. The rights and remedies
herein provided shall be cumulative and not exclusive of any rights or remedies provided by law. 
 Section 7. Successors and
Assigns. The provisions of this Agreement shall be binding upon and inure to the benefit of the parties hereto and their respective successors and assigns; provided that no party may assign, delegate or
otherwise transfer any of its rights or obligations under this Agreement without the consent of each other party hereto. 

 Section 8. Choice of Law and Venue. Without regard to
principles of conflicts of law, this Agreement shall be construed and enforced in accordance with and governed by the laws of the State of New York. The Parties agree that venue shall be in any state court or the United States District Court located
in New York, New York. Each party consents to the exclusive jurisdiction of such courts (and the appellate courts thereof) and agrees not to commence any such proceeding except in such courts. Each party agrees not to assert (by way of motion, as a
defense, or otherwise), and hereby irrevocably and unconditionally waives in any such proceeding commenced in such court, any objection or claim that such party is not subject personally to the jurisdiction of such court or that such proceeding has
been brought in an inconvenient forum. If such courts refuse to exercise jurisdiction hereunder, the Parties agree that such jurisdiction shall be proper in any court in which jurisdiction may be obtained. 

Section 9. Waiver of Jury Trial. EACH PARTY TO THIS AGREEMENT HEREBY EXPRESSLY WAIVES ANY RIGHT TO TRIAL
BY JURY OF ANY CLAIM, DEMAND, ACTION OR CAUSE OF ACTION (1) ARISING UNDER THIS AGREEMENT OR ANY OTHER INSTRUMENT, DOCUMENT OR AGREEMENT EXECUTED OR DELIVERED IN CONNECTION HEREWITH, OR (2) IN ANY WAY CONNECTED WITH OR RELATED OR INCIDENTAL
TO THE DEALINGS OF THE PARTIES HERETO OR ANY OF THEM WITH RESPECT TO THIS AGREEMENT OR ANY OTHER INSTRUMENT, DOCUMENT OR AGREEMENT EXECUTED OR DELIVERED IN CONNECTION HEREWITH, OR THE TRANSACTIONS RELATED HERETO OR THERETO, IN EACH CASE WHETHER NOW
EXISTING OR HEREAFTER ARISING AND WHETHER SOUNDING IN CONTRACT OR TORT OR OTHERWISE; AND EACH PARTY HEREBY AGREES AND CONSENTS THAT ANY SUCH CLAIM, DEMAND, ACTION OR CAUSE OF ACTION SHALL BE DECIDED BY COURT TRIAL WITHOUT A JURY, AND THAT ANY PARTY
TO THIS AGREEMENT MAY FILE AN ORIGINAL COUNTERPART OR A COPY OF THIS SECTION WITH ANY COURT AS WRITTEN EVIDENCE OF THE CONSENT OF THE PARTIES HERETO TO THE WAIVER OF THEIR RIGHT TO TRIAL BY JURY. 

Section 10. Counterparts; Third Party Beneficiaries. This Agreement may be signed in any number of counterparts,
each of which shall be an original, with the same effect as if the signatures thereto and hereto were upon the same instrument. This Agreement shall become effective when each party hereto shall have received a counterpart hereof signed by the other
party hereto. No provision of this Agreement shall confer upon any person other than the parties hereto any rights or remedies hereunder. 

Section 11. Entire Agreement. This Agreement constitutes the entire agreement between the parties with respect to
the subject matter of this Agreement and supersedes all prior agreements and understandings, both oral and written, between the parties with respect to the subject matter of this Agreement. 

Section 12. Captions. The captions herein are included for convenience of reference only and shall be ignored in
the construction or interpretation hereof. 

 This Subscription Agreement is executed as of the date first written above. 

 

			
	QUOTIENT LIMITED
		
	By:	 	/s/ Christopher Lindop
		 	Name: Christopher Lindop
		 	Title: Chief Financial Officer
	
	HEINO VON PRONDZYNSKI
		
	By:	 	/s/ Heino von ProndzynskiEX-10.2

 Exhibit 10.2 

CONSULTING AGREEMENT 

This Consulting Agreement (the “Agreement”), made this ____ day of May, 2018 is entered into by and between Achillion
Pharmaceuticals, Inc. (the “Company”), and Milind Deshpande, Ph.D. (the “Consultant”). 
 WHEREAS, the
Company wishes to engage the Consultant to provide certain scientific advisory services to the Company, and the Consultant wishes to provide such services to the Company, in each case subject to the terms and conditions of this Agreement; 

NOW, THEREFORE in consideration of the mutual covenants and promises contained herein and other good and valuable consideration, the receipt
and sufficiency of which is hereby acknowledged by the parties hereto, the parties agree as follows: 
 1. Engagement and Performance of
Services. The Company hereby engages the Consultant to perform the scientific advisory services described in Schedule A (the “services”). The Consultant shall perform the services one workday each week (or the equivalent
thereof) at such locations as may mutually be agreed upon by the parties. In performing the services, the Consultant shall comply with all applicable laws and regulations, and shall perform the services in a manner that is consistent with relevant
industry and professional standards.  
 2. Term. This Agreement shall commence on May 18, 2018 (the
“Effective Date”) and shall continue until the one-year anniversary of the Effective Date, unless the Agreement is extended by written mutual agreement of the parties or terminated earlier in
accordance with the provisions of Section 4 below (such period, the “Consultation Period”). 
 3. Compensation.

 3.1 Equity Vesting and Exercise. During the Consultation Period, and in accordance with the terms of the option agreements
governing the options granted to the Consultant during his employment with the Company, all of the Consultant’s options will continue to vest and be exercisable. Following the end of the Consultation Period, the Consultant will have three
months to exercise his vested stock options. 
 3.2 Benefits. The Consultant shall not be entitled to any benefits, coverages or
privileges, including, without limitation, health insurance, social security, unemployment, medical or pension payments, made available to employees of the Company. 

4. Termination. This Agreement may be terminated in the following manner: (a) by either the Company or the Consultant upon not
less than thirty (30) days prior written notice to the other party; (b) by the non-breaching party, upon twenty-four (24) hours prior written notice to the breaching party if one party has
materially breached this Agreement; or (c) at any time upon the mutual written consent of the parties hereto. Notwithstanding the foregoing, the Company may terminate this Agreement effective immediately by giving written notice to the
Consultant if the Consultant breaches or threatens to breach any provision of Sections 6 or 7, the Restrictive Covenant Agreement (as defined below), or any severance and release of claims agreement between the Company and the Consultant. 

 5. Cooperation. The Consultant shall use the Consultant’s best efforts in the
performance of the Consultant’s obligations under this Agreement. The Company shall provide such access to its information and property as may be reasonably required in order to permit the Consultant to perform the Consultant’s obligations
hereunder. The Consultant shall cooperate with the Company’s personnel, shall not interfere with the conduct of the Company’s business and shall observe all rules, regulations and security requirements of the Company concerning the safety
of persons and property. 
 6. Non-Disclosure, Assignment of Inventions and Restrictive
Covenants. 
 6.1 Proprietary Information. 

(a) The Consultant acknowledges that the Consultant’s relationship with the Company is one of high trust and confidence and that in the
course of the Consultant’s service to the Company, the Consultant will have access to and contact with Proprietary Information (as defined below). Except as otherwise permitted by Section 6.1(f), the Consultant will not disclose any
Proprietary Information to any person or entity other than employees of the Company or use the same for any purposes (other than in the performance of the services) without written approval by an officer of the Company, either during or after the
Consultation Period. 
 (b) For purposes of this Agreement, Proprietary Information shall mean, by way of illustration and not limitation,
all information, whether or not in writing, whether or not patentable and whether or not copyrightable, of a private, secret or confidential nature, owned, possessed or used by the Company, concerning the Company’s business, business
relationships or financial affairs, including, without limitation, any Invention (as defined below), formula, vendor information, customer information, supplier information, apparatus, equipment, trade secret, process, research, report, technical or
research data, clinical data, know-how, computer program, software, software documentation, hardware design, technology, product, processes, methods, techniques, formulas, compounds, projects, developments,
marketing or business plan, forecast, unpublished financial statement, budget, license, price, cost, or employee list that is communicated to, learned of, developed or otherwise acquired by the Consultant in the course of the Consultant’s
service as a consultant to the Company. 
 (c) The Consultant agrees that all files, documents, letters, memoranda, reports, records, data,
sketches, drawings, models, laboratory notebooks, program listings, computer equipment or devices, computer programs or other written, photographic, or other tangible material containing Proprietary Information, whether created by the Consultant or
others, which shall come into the Consultant’s custody or possession, shall be and are the exclusive property of the Company to be used by the Consultant only in the performance of the Consultant’s services for the Company and shall not be
copied or removed from the Company’s premises except in the pursuit of the business of the Company. All such materials or copies thereof and all tangible property of the Company in the custody or possession of the Consultant shall be delivered
to the Company, upon the earlier of (i) a request by the Company or (ii) the termination of this Agreement. After such delivery, the Consultant shall not retain any such materials or copies thereof or any such tangible property. 

  
 - 2 - 

 (d) The Consultant agrees that the Consultant’s obligation not to disclose or to use
information and materials of the types set forth in paragraphs (b) and (c) above, and the Consultant’s obligation to return materials and tangible property set forth in paragraph (c) above extends to such types of information,
materials and tangible property of customers of the Company or suppliers to the Company or other third parties who may have disclosed or entrusted the same to the Company or to the Consultant. 

(e) The Consultant acknowledges that the Company from time to time may have agreements with other persons or with the United States
Government, or agencies thereof, that impose obligations or restrictions on the Company regarding inventions made during the course of work under such agreements or regarding the confidential nature of such work. The Consultant agrees to be bound by
all such obligations and restrictions that are known to the Consultant and to take all action necessary to discharge the obligations of the Company under such agreements. 

(f) The Consultant’s obligations under this Section 6.1 shall not apply to any information that (i) is or becomes known to the
general public under circumstances involving no breach by the Consultant or others of the terms of this Section 6.1, (ii) is generally disclosed to third parties by the Company without restriction on such third parties, or (iii) is
approved for release by written authorization of an officer of the Company. Further, nothing in this Agreement prohibits the Consultant from communicating with government agencies about possible violations of federal, state, or local laws or
otherwise providing information to government agencies or participating in government agency investigations or proceedings. The Consultant is not required to notify the Company of any such communications; provided, however, that nothing herein
authorizes the disclosure of information the Consultant obtained through a communication that was subject to the attorney-client privilege. Further, notwithstanding the Consultant’s confidentiality and nondisclosure obligations, the Consultant
is hereby advised as follows pursuant to the Defend Trade Secrets Act: “An individual shall not be held criminally or civilly liable under any Federal or State trade secret law for the disclosure of a trade secret that (A) is made
(i) in confidence to a Federal, State, or local government official, either directly or indirectly, or to an attorney; and (ii) solely for the purpose of reporting or investigating a suspected violation of law; or (B) is made in a
complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal. An individual who files a lawsuit for retaliation by an employer for reporting a suspected violation of law may disclose the trade secret to the
attorney of the individual and use the trade secret information in the court proceeding, if the individual (A) files any document containing the trade secret under seal; and (B) does not disclose the trade secret, except pursuant to court
order.” 
 6.2 Inventions. 

(a) The Consultant will make full and prompt disclosure to the Company of all discoveries, ideas, inventions, creations, designs,
innovations, improvements, enhancements, processes, methods, techniques, developments, software, computer programs, and works of authorship (whether or not patentable and whether or not copyrightable) which are made, conceived, reduced to practice,
created, written, designed or developed by the Consultant, solely or jointly with others or under the Consultant’s direction and whether during normal business hours or on the premises of the Company or otherwise (i) during the
Consultation Period if related to the 

  
 - 3 - 

 business of the Company or research and development conducted or planned to be conducted by the Company or
(ii) after the Consultation Period if resulting or directly derived from Proprietary Information (collectively under clauses (i) and (ii), “Inventions”). The Consultant agrees to assign and hereby assigns to the Company
(or any person or entity designated by the Company) all of the Consultant’s right, title and interest in and to all Inventions and any and all related patents, patent applications, copyrights created in the work(s) of authorship, trademarks,
trade names, and other industrial and intellectual property rights and applications therefor, in the United States and elsewhere, and appoints any officer of the Company as the Consultant’s duly authorized attorney to execute, file, prosecute
and protect the same before any government agency, court or authority. This paragraph shall not apply to Inventions which both (1) do not relate to the business or research and development conducted or planned to be conducted by the Company at
the time such Invention is created, made, conceived or reduced to practice, and (2) are made and conceived by the Consultant not during normal working hours, not on the Company’s premises and not using the Company’s tools, devices,
equipment or Proprietary Information. The Consultant further acknowledges that each original work of authorship which is made by the Consultant (solely or jointly with others) within the scope of the Agreement and which is protectable by copyright
is a “work made for hire,” as that term is defined in the United States Copyright Act. 
 (b) The Consultant agrees that if, in
the course of performing the services, the Consultant incorporates into any Invention developed under this Agreement any preexisting invention, improvement, development, concept, discovery or other proprietary information owned by the Consultant or
in which the Consultant has an interest (“Prior Inventions”), (i) the Consultant will inform the Company, in writing before incorporating such Prior Inventions into any Invention, and (ii) the Company is hereby granted a
nonexclusive, royalty-free, perpetual, irrevocable, transferable worldwide license with the right to grant and authorize sublicenses, to make, have made, modify, use, import, offer for sale, sell, reproduce, distribute, modify, adapt, prepare
derivative works of, display, perform, and otherwise exploit such Prior Inventions, without restriction, including, without limitation, as part of or in connection with such Invention, and to practice any method related thereto. The Consultant will
not incorporate any invention, improvement, development, concept, discovery or other proprietary information owned by any third party into any Invention without the Company’s prior written permission. 

(c) Upon the request of the Company and at the Company’s expense, the Consultant shall execute such further assignments, documents and
other instruments as may be necessary or desirable to fully and completely assign all Inventions to the Company and to assist the Company in applying for, obtaining and enforcing patents or copyrights or other rights in the United States and in any
foreign country with respect to any Invention. The Consultant also hereby waives all claims to moral rights in any Inventions. 
 (d) The
Consultant shall maintain adequate and current written records (in the form of notes, sketches, drawings and as may be specified by the Company) to document the conception and/or first actual reduction to practice of any Invention. Such written
records shall be available to and remain the sole property of the Company at all times. 
 7.
Non-Solicitation. During the Consultation Period and for a period of six (6) months thereafter, the Consultant shall not, directly or indirectly, recruit or solicit, or attempt to recruit or
solicit, any person who was employed by the Company or engaged as an independent contractor for the Company at any time during the Consultation Period, except for an individual whose employment with or service for the Company has been terminated for
a period of six (6) months or longer. 

  
 - 4 - 

 8. Other Agreements; Warranty. 

8.1 The Consultant hereby represents that, except as the Consultant has disclosed in writing to the Company, the Consultant is not bound by
the terms of any agreement with any third party to refrain from using or disclosing any trade secret or confidential or proprietary information in the course of the Consultant’s consultancy with the Company, to refrain from competing, directly
or indirectly, with the business of such third party or to refrain from soliciting employees, customers or suppliers of such third party. The Consultant further represents that the Consultant’s performance of all the terms of this Agreement and
the performance of the services as a consultant of the Company do not and will not breach any agreement with any third party to which the Consultant is a party (including, without limitation, any nondisclosure or
non-competition agreement), and that the Consultant will not disclose to the Company or induce the Company to use any confidential or proprietary information or material belonging to any current or previous
employer or others. 
 8.2 The Consultant hereby represents, warrants and covenants that the Consultant has the skills and experience
necessary to perform the services, that the Consultant will perform said services in a professional, competent and timely manner, that the Consultant has the power to enter into this Agreement and that the Consultant’s performance hereunder
will not infringe upon or violate the rights of any third party or violate any federal, state or municipal laws. 
 9. Independent
Contractor Status. 
 9.1 The Consultant shall perform all services under this Agreement as an “independent contractor” and
not as an employee or agent of the Company. The Consultant is not authorized to assume or create any obligation or responsibility, express or implied, on behalf of, or in the name of, the Company or to bind the Company in any manner. 

9.2 The Consultant shall have the right to control and determine the time, place, methods, manner and means of performing the services. In
performing the services, the amount of time devoted by the Consultant on any given day will be entirely within the Consultant’s control, and the Company will rely on the Consultant to put in the amount of time necessary to fulfill the
requirements of this Agreement. The Consultant will provide all equipment and supplies required to perform the services. The Consultant is not required to attend regular meetings at the Company. However, upon reasonable notice, the Consultant shall
meet with representatives of the Company at a location to be designated by the parties to this Agreement. 
 9.3 In the performance of the
services, the Consultant has the authority to control and direct the performance of the details of the services, the Company being interested only in the results obtained. However, the services contemplated by the Agreement must meet the
Company’s standards and approval and shall be subject to the Company’s general right of inspection and supervision to secure their satisfactory completion. 

  
 - 5 - 

 9.4 The Consultant shall not use the Company’s trade names, trademarks, service names or
service marks without the prior approval of the Company. 
 9.5 The Consultant shall be solely responsible for all state and federal income
taxes, unemployment insurance and social security taxes in connection with this Agreement and for maintaining adequate workers’ compensation insurance coverage. 

10. Non-Exclusivity. The Company retains a right to contract with other companies and/or
individuals for consulting services without restriction. The Consultant similarly retains the right to contract with other companies or entities for the Consultant’s consulting services; provided, however, and for the avoidance of doubt, that
the Consultant remains bound by the non-competition obligations set forth in the Nondisclosure, Assignment of Inventions and Post-Employment Covenants Agreement (the “Restrictive Covenant Agreement”)
the Consultant previously executed for the benefit of the Company, which remains in full force and effect. 
 11. Remedies. The
Consultant acknowledges that any breach of the provisions of Sections 6 or 7 of this Agreement shall result in serious and irreparable injury to the Company for which the Company cannot be adequately compensated by monetary damages alone. The
Consultant agrees, therefore, that, in addition to any other remedy the Company may have, the Company shall be entitled to enforce the specific performance of this Agreement by the Consultant and to seek both temporary and permanent injunctive
relief (to the extent permitted by law) without the necessity of proving actual damages or posting a bond. 
 12. Indemnification.
The Consultant shall be solely liable for, and shall indemnify, defend and hold harmless the Company and its successors and assigns from any claims, suits, judgments or causes of action initiated by any third party against the Company where such
actions result from or arise out of the Consultant’s misfeasance or malfeasance in the performance of services performed by the Consultant under this Agreement. The Consultant shall further be solely liable for, and shall indemnify, defend and
hold harmless the Company and its successors and assigns from and against any claim or liability of any kind (including penalties, fees or charges) resulting from the Consultant’s failure to pay the taxes, penalties, and payments referenced in
Section 9 of this Agreement. The Consultant shall further indemnify, defend and hold harmless the Company and its successors and assigns from and against any and all loss or damage resulting from any misrepresentation, or any non-fulfillment of any representation, responsibility, covenant or agreement on the Consultant’s part, as well as any and all acts, suits, proceedings, demands, assessments, penalties, judgments of or against
the Company relating to or arising out of the activities of the Consultant and the Consultant shall pay reasonable attorneys’ fees, costs and expenses incident thereto. 

13. Notices. Any notice delivered under this Agreement shall be deemed duly delivered 3 business days after it is sent by registered or
certified mail, return receipt requested, postage prepaid, or one business day after it is sent for next-business day delivery via a reputable nationwide overnight courier service, to the Company at its principal headquarters and to the Consultant
at the address most recently shown in the records of the Company. Either party may change the address to which notices are to be delivered by giving notice of such change to the other party in the manner set forth in this Section 13. 

  
 - 6 - 

 14. Pronouns. Whenever the context may require, any pronouns used in this Agreement shall
include the corresponding masculine, feminine or neuter forms, and the singular forms of nouns and pronouns shall include the plural, and vice versa. 

15. Entire Agreement. This Agreement constitutes the entire agreement between the parties pertaining to the Consultant’s
engagement by the Company as an independent contractor, and supersedes all prior agreements and understandings, whether written or oral, relating thereto. For the avoidance of doubt, nothing herein supersedes the Restrictive Covenant Agreement that
the Consultant previously executed for the benefit of the Company, which remains in full force and effect, nor does anything herein supersede any severance and release of claims agreement between the Consultant and the Company. 

16. Amendment. This Agreement may be amended or modified only by a written instrument executed by both the Company and the Consultant.

 17. Non-Assignability of Contract. This Agreement is personal to the Consultant and the
Consultant shall not have the right to assign any of the Consultant’s rights or delegate any of the Consultant’s duties without the express written consent of the Company. Any
non-consented-to assignment or delegation, whether express or implied or by operation of law, shall be void and shall constitute a breach and a default by the
Consultant. 
 18. Governing Law, Forum and Jurisdiction. This Agreement shall be governed by and construed in accordance with the
laws of the State of Connecticut (without reference to the conflicts of laws provisions thereof). Any action, suit, or other legal proceeding which is commenced to resolve any matter arising under or relating to any provision of this Agreement shall
be commenced only in a court of the State of Connecticut or, if appropriate, a federal court located within the State of Connecticut, and the Company and the Consultant each consents to the jurisdiction of such a court. The Company and the
Consultant each hereby irrevocably waives any right to a trial by jury in any action, suit or other legal proceeding arising under or relating to any provision of this Agreement. 

19. Successors and Assigns. This Agreement shall be binding upon, and inure to the benefit of, both parties and their respective
successors and assigns, including any corporation with which, or into which, the Company may be merged or which may succeed to its assets or business, provided, however, that the obligations of the Consultant are personal and shall not be assigned
by the Consultant. 
 20. Interpretation. If any restriction set forth in Section 7 is found by any court of competent
jurisdiction to be unenforceable because it extends for too long a period of time or over too great a range of activities or in too broad a geographic area, it shall be interpreted to extend only over the maximum period of time, range of activities
or geographic area as to which it may be enforceable. 
 21. Survival. Sections 4 through 22 shall survive the expiration or
termination of this Agreement. 

  
 - 7 - 

 22. Miscellaneous. 

22.1 No delay or omission by the Company in exercising any right under this Agreement shall operate as a waiver of that or any other right. A
waiver or consent given by the Company on any one occasion shall be effective only in that instance and shall not be construed as a bar to or waiver of any right on any other occasion. 

22.2 The captions of the sections of this Agreement are for convenience of reference only and in no way define, limit or affect the scope or
substance of any section of this Agreement. 
 22.3 In the event that any provision of this Agreement shall be invalid, illegal or otherwise
unenforceable, the validity, legality and enforceability of the remaining provisions shall in no way be affected or impaired thereby. 

[Remainder of Page Intentionally Left Blank] 

  
 - 8 - 

 IN WITNESS WHEREOF, the parties hereto have executed this Consulting Agreement as of the date and
year first above written. 
  

					
	COMPANY:
	
	ACHILLION PHARMACEUTICALS, INC
		
	By:	 	/s/ Joseph Truitt
		 	Name:	 	Joseph Truitt
		 	Title:	 	President & CEO
	
	 MILIND DESHPANDE, PH.D.

	
	/s/ Milind Deshpande

 SIGNATURE PAGE TO CONSULTING AGREEMENT 

 SCHEDULE A 

DESCRIPTION OF SERVICES 

Consultant will provide Services at the request of Achillion and with the agreement of Consultant based on the mutual agreement of the
parties, related to scientific and other related matters as requested by Achillion.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00286-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00286-of-00352.parquet"}]]